1. Recent Milestones:        

Launch in 2023 of the Kaleido wearable insulin patch pump system in FR, GER & NL
CE marked and reimbursed in all EU markets
Strategic partnerships with Diabeloop (Automated Insulin Delivery, AID) and Dexcom (glucose sensor, CGM)
Inhouse manufacturing fully qualified in Utrecht, NL

2. Upcoming Milestones:

2024/2025: Expansion to other EU countries with US Launch in 2026
2024: Launch of smartphone control (iOS & Android)
2025/2026: Launch of Kaleido gen 2 with improved design & usability

Products:
Lead product is Kaleido, a best-in-class wearable insulin patch pump system, which automatically delivers insulin via an AI-powered dosing algorithm. It is the only body-worn, fully durable pump (used for 4 years) on the market.

Investors:
EQT, Partners in Equity, INKEF, Invest-NL, Health Innovations

Full Company address & contact details:
Leo Toole CFO; leo.toole@vicentra.com
+31 (0) 88 2502 900
www.hellokaleido.com
ViCentra B.V, Rijnzathe 6, 3454 PV Utrecht, The Netherlands